Premium listings
  • 3rd International Conference on Transcriptomics

    3rd International Conference on Transcriptomics

    Life Sciences Bangkok (Bangkok) March 13, 2017 Check with publisher

    Conference Series has been instrumental in conducting international Biochemistry meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Philadelphia, Orlando ...

  • Developing drugs for the treatment of neurodegenerative diseases

    Developing drugs for the treatment of neurodegenerative diseases

    PhD Studentships Liverpool December 3, 2016 Check with publisher

    Ageing is arguably the major biomedical challenge of the 21st century with the incidence of age-related diseases, and neurodegenerative diseases in particular, expected to increase dramatically in the coming decades. In model organisms, the process o...

  • DrugAge database of compounds that increase lifespan

    DrugAge database of compounds that increase lifespan

    Biomedical Sciences Liverpool August 24, 2015 Check with publisher

    We're starting a new database of drugs and compounds (including natural products) with anti-ageing properties that extend longevity in model organisms. The database will be called DrugAge, and although we have some data already, we are looking for da...

Listings
  • Drug Products for Clinical Trials | FDA Approved Drugs List 2018

    Drug Products for Clinical Trials | FDA Approved Drugs List 2018

    Training and Teaching Boston, MA (Boston) January 19, 2018 1295.00 Dollar US$

    Course "Different requirements for Phase I Investigational Drug Products: which GMPs apply since most Phase I drugs are exempt from full GMP requirements and what IND data requirements are necessary as a result?" has been pre-approved by RAPS as elig...

  • Anti-TPBG (clone A1)-AcBut-calicheamicin ADC

    Anti-TPBG (clone A1)-AcBut-calicheamicin ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via an AcBut linker to calicheamicin. The calicheamicin is targeted to TPBG-positive cancers by immunerec...

  • Anti-TPBG (clone A1)-SMCC-DMA ADC

    Anti-TPBG (clone A1)-SMCC-DMA ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    http://science-marketplace.org/services/drug-development_1/anti-tpbg-clone-a1-smcc-dma-adc_i3004 This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a SMCC linker to DMA. The DMA is targeted to TPBG-positive ca...

  • Anti-FUT3 (clone hu3S193)-AcBut-CalichDMH ADC

    Anti-FUT3 (clone hu3S193)-AcBut-CalichDMH ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fut3-48.htm This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone hu3S193) conjugated via a AcBut linker to CalichDMH. The CalichDMH is targeted to certain cancers by immunerecognition an...

  • Anti-FOLR1-S-S-Dox ADC

    Anti-FOLR1-S-S-Dox ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folr1-47.htm This ADC product is comprised of an anti-FOLR1 monoclonal antibody conjugated via a linker to Dox. The Dox is targeted to certain cancers by immunerecognition and delivered into cancer cells vi...

  • Anti-FOLR1 (clone M9346A)-sulfo-SPDB-DM4 ADC

    Anti-FOLR1 (clone M9346A)-sulfo-SPDB-DM4 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folr1-47.htm This ADC product is comprised of an anti-FOLR1 monoclonal antibody (clone M9346A)conjugated via a sulfo-SPDB linker to a DM4. The DM4 is targeted to certain cancers by immunerecognition and del...

  • Anti-FOLR1 (M9346A)-SPDB-DM4 ADC

    Anti-FOLR1 (M9346A)-SPDB-DM4 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folh1-46.htm This ADC product is comprised of an anti-FOLR1 monoclonal antibody (M9346A) conjugated via a SPDB linker to DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered into c...

  • Anti-FOLH1 (clone J591)-SMCC-DM1 ADC

    Anti-FOLH1 (clone J591)-SMCC-DM1 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folh1-46.htm This ADC product is comprised of an anti-FOLH1 monoclonal antibody (clone J591) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered in...

  • Anti-FLAG-SPDP-NCS ADC

    Anti-FLAG-SPDP-NCS ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-flag-44.htm This ADC product is comprised of an anti-FLAG monoclonal antibody conjugated via a SPDP linker to NCS. The NCS is targeted to certain cancers by immunerecognition and delivered into cancer cells...

  • Anti-FGFR2 (clone 12433)-SPDB-DM4 ADC

    Anti-FGFR2 (clone 12433)-SPDB-DM4 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-fgfr2-43.htm This ADC product is comprised of an anti-FGFR2 monoclonal antibody (clone 12433) conjugated via a SPDB linker to DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered i...

  • How to Accurate Adverse Event Reporting

    How to Accurate Adverse Event Reporting

    Training and Teaching Fremont (California) December 8, 2017 150.00 Dollar US$

    Overview: Learn why the single most important function of the Principal Investigator and the study conduct team is the awareness, assessment, and management of Adverse Events occurring during the conduct of clinical research with drugs or devices uti...

  • Anti-EpCAM-sulfo-SPDB-DM4 ADC

    Anti-EpCAM-sulfo-SPDB-DM4 ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-EpCAM monoclonal antibody conjugated via a sulfo-SPDB linker to DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce...